Concepedia

David Charbonnier

DC

Statistics

Publications

5

Citations

333

H-Index

5

Active since

2018

Affiliations

Centro de Investigacion Principe Felipe(Current)

David Charbonnier is an author at Centro de Investigacion Principe Felipe specializing in pharmacology, pharmacy, and drug delivery.

ORCID

Publications per year

2018–2022

5

Publications

5

Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression

Juan J. Arroyo‐Crespo, Ana Armiñán, David Charbonnier et al. · International Journal of Cancer · 2019 · 129 citations · Full text

, , +17

Tumor microenvironment-targeted poly-L-glutamic acid-based combination conjugate for enhanced triple negative breast cancer treatment

Juan J. Arroyo‐Crespo, Ana Armiñán, David Charbonnier et al. · Biomaterials · 2018 · 74 citations · Full text

, , +17

Polyglutamic acid-based crosslinked doxorubicin nanogels as an anti-metastatic treatment for triple negative breast cancer

Aroa Duro‐Castaño, Ana Sousa‐Herves, Ana Armiñán et al. · Journal of Controlled Release · 2021 · 59 citations · Full text

, , +16

Anticancer Activity Driven by Drug Linker Modification in a Polyglutamic Acid‐Based Combination‐Drug Conjugate

Juan J. Arroyo‐Crespo, Coralie Deladriere, Vicent J. Nebot et al. · Advanced Functional Materials · 2018 · 47 citations · Full text

, , +17

PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease

Maite Duhalde Vega, Daniela Olivera, Gustavo Gastão Davanzo et al. · Science Advances · 2022 · 24 citations · Full text

, , +17

1–5 of 5